May. 13 at 10:05 AM
☀️
$TNYA — Day 3 begins. Bulls didn’t blink. 💪
Pre-market:
$1.03 (+3%) at 6 AM 📈
Let’s recap what shorts tried yesterday:
❌ Crack
$1.00 — FAILED (closed
$1.00)
❌ Defend
$0.96 — FAILED (bought every test)
❌ Plant fake “reverse split” rumor — DEBUNKED (zero in the proxy 📄)
❌ Plant fake “CEO leaving” rumor — DEBUNKED (Ali signed the April letter as CEO ✍️)
❌ Force capitulation on 220% volume — FAILED (AH stayed flat
$1.00)
Two full sessions of war. Bulls control every key level. 🛡️
Now the calendar is WORKING AGAINST SHORTS every hour 👇
📅 TODAY (Wed May 13): Conference live in Boston. Possible early abstract releases. Algos start positioning.
📅 TOMORROW (Thu May 14): TN-501 preclinical data at ASGCT 🎁 — bonus pipeline drop the day before the main event
📅 FRIDAY (May 15):
⏰ ~8 AM ET — TN-401 RIDGE-1 press release
⏰ 8-9 AM ET — Late-breaker oral session
⏰ 10:30 AM ET — Management investor webcast 📞
🔥 What the May 6 earnings release CONFIRMED:
✅ LATE-BREAKER status — ASGCT upgrades the data quality bar 📈
✅ TWO cohorts of data Friday (1-yr C1 durability + initial C2 high-dose)
✅ DSMB pre-cleared safety at both doses 🛡️
✅
$90.9M cash, runway 2H 2027 — NO RAISE NEEDED 💰
✅ R&D burn DOWN 28% YoY (cost discipline)
✅ TN-201 second binary now Q2 2026 (by June 30) — tightened from “1H”
✅ CEO targeting registrational pathway discussions with FDA 🎯
Short setup heading into the most important day:
🩸 22.91% short float | 19.59M shares trapped
🩸 5.6 days to cover (with the binary in 2 sessions, time is OUT)
🩸 Float locked up by Citadel, Empery, Anson, Alyeska, Marshall Wace +8,034%, Jane Street +334%, BlackRock +70%, Vanguard +69% 🐋
Technical setup:
📊 RSI(14): 70 — momentum hot, base since
$0.62 = 6 weeks
📊 MACD: bullish cross May 4, histogram EXPANDING 6 sessions in
📊 Bollinger: riding the upper band (
$1.00 vs
$0.99 upper) = momentum continuation
📊 All MAs stacked bullish (price > SMA10 > SMA20 > SMA50)
📊 2-day volume: 25M = 26% of float traded → tightening fast
This is what a stock looks like THREE SESSIONS before a positive catalyst with the dilution risk MOSTLY DRAINED.
Three sessions. The shorts have ONE play left: break weak hands. They’ve failed twice. They’ll try again.
Don’t sell them what they need. 💎🙌
$TNYA #shortsqueeze #biotech #genetherapy #ASGCT2026
Not financial advice. DYOR — and that means reading the May 6 10-Q and 8-K, not whispers.
